Status:

COMPLETED

Minimally Invasive Treatment of Primary Great Saphenous Vein (GSV) Insufficiency Using High Intensity Focused Ultrasound (HIFU)

Lead Sponsor:

Englewood Hospital and Medical Center

Conditions:

Great Saphenous Vein Insufficiency

Eligibility:

All Genders

22+ years

Phase:

NA

Brief Summary

This is a one-arm, open label, prospective, single-center study. Primary objective To evaluate the feasibility of HIFU for treatment of Great Saphenous Vein using assessments of patient experience and...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Candidate for venous procedure with primary GSV insufficiency involving reflux in the segment to be treated
  • CEAP-clinical classification ≥ 2
  • Physical condition allowing ambulation after the procedure.
  • Agree to comply with the Clinical investigation plan and follow-up schedule of the study
  • Targeted tissue reachable for treatment with the device - meaning between 5mm and 24mm below the skin surface.
  • Age over 22 years at the time of enrollment.
  • No acute venous thrombosis.
  • No complete or near complete deep vein post-thrombotic disease.
  • Patient has signed and understood the written informed consent.
  • Exclusion criteria
  • Patient is pregnant
  • Known allergic reaction to anesthetics to be used.
  • Legally incapacitated or imprisoned patients
  • Patient's vein target not clearly visible on the ultrasound images (in B mode) at the inclusion visit.
  • Patient participating in another clinical trial involving an investigational drug or device.
  • Ankle-brachial index \<7 (ABI)
  • Undergoing active anticoagulant therapy within the last 6 months
  • Diameter of the treated anatomical segment below ≤ 2mm
  • \-

Exclusion

    Key Trial Info

    Start Date :

    March 23 2022

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    January 31 2023

    Estimated Enrollment :

    20 Patients enrolled

    Trial Details

    Trial ID

    NCT05193643

    Start Date

    March 23 2022

    End Date

    January 31 2023

    Last Update

    April 19 2023

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Englewood Health

    Englewood, New Jersey, United States, 07631